Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort studyNarendranath Epperla, Reem Karmali, Catherine J. Lee et al.|Journal of Hematology & Oncology|2023Cited by 52
Consensus recommendations from the 2024 Lymphoma Research Foundation workshop on treatment selection and sequencing in CLL or SLLJacob D. Soumerai, Deborah M. Stephens, Jacqueline C. Barrientos et al.|Blood Advances|2024Cited by 19
A phase II, randomized study of nivolumab (NIVO) and Ipilimumab (IPI) versus NIVO, IPI and stereotactic body radiation therapy (SBRT) for metastatic Merkel cell carcinoma (MCC, NCT03071406): A preliminary reportS. Kim, Andrew S. Brohl, Nikhil I. Khushalani et al.|Annals of Oncology|2019Cited by 5